These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox to the elbow flexors in a unilateral stroke population. Pandyan AD, Vuadens P, van Wijck FM, Stark S, Johnson GR, Barnes MP. Clin Rehabil; 2002 Sep; 16(6):654-60. PubMed ID: 12392341 [Abstract] [Full Text] [Related]
3. Measuring spasticity and fine motor control (pinch) change in the hand after botulinum toxin-A injection using dynamic computerized hand dynamometry. Barden HL, Baguley IJ, Nott MT, Chapparo C. Arch Phys Med Rehabil; 2014 Dec; 95(12):2402-9. PubMed ID: 24909588 [Abstract] [Full Text] [Related]
5. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens. Slawek J, Bogucki A, Reclawowicz D. Neurol Sci; 2005 Apr; 26(1):32-9. PubMed ID: 15877185 [Abstract] [Full Text] [Related]
9. Modulation of cortical activity in patients suffering from upper arm spasticity following stroke and treated with botulinum toxin A: an fMRI study. Senkárová Z, Hlustík P, Otruba P, Herzig R, Kanovský P. J Neuroimaging; 2010 Jan; 20(1):9-15. PubMed ID: 19453837 [Abstract] [Full Text] [Related]
10. Effectiveness of Extracorporeal Shock Wave Therapy after Botulinum Toxin Injection for Post-Stroke Upper Extremity Spasticity: A Randomized Controlled Study. Lee J, Yang SN. Toxins (Basel); 2024 Apr 19; 16(4):. PubMed ID: 38668622 [Abstract] [Full Text] [Related]
12. Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques. Santamato A, Micello MF, Panza F, Fortunato F, Baricich A, Cisari C, Pilotto A, Logroscino G, Fiore P, Ranieri M. J Neurol Sci; 2014 Dec 15; 347(1-2):39-43. PubMed ID: 25263601 [Abstract] [Full Text] [Related]
13. Robot-mediated and clinical scales evaluation after upper limb botulinum toxin type A injection in children with hemiplegia. Frascarelli F, Masia L, Di Rosa G, Petrarca M, Cappa P, Castelli E. J Rehabil Med; 2009 Nov 15; 41(12):988-94. PubMed ID: 19841830 [Abstract] [Full Text] [Related]
16. Efficacy and safety of NABOTA in post-stroke upper limb spasticity: a phase 3 multicenter, double-blinded, randomized controlled trial. Nam HS, Park YG, Paik NJ, Oh BM, Chun MH, Yang HE, Kim DH, Yi Y, Seo HG, Kim KD, Chang MC, Ryu JH, Lee SU. J Neurol Sci; 2015 Oct 15; 357(1-2):192-7. PubMed ID: 26233808 [Abstract] [Full Text] [Related]
17. Comparative impact of 2 botulinum toxin injection techniques for elbow flexor hypertonia. Mayer NH, Whyte J, Wannstedt G, Ellis CA. Arch Phys Med Rehabil; 2008 May 15; 89(5):982-7. PubMed ID: 18452749 [Abstract] [Full Text] [Related]
18. Further assessment to determine the additive effect of botulinum toxin type A on an upper extremity exercise program to enhance function among individuals with chronic stroke but extensor capability. Wolf SL, Milton SB, Reiss A, Easley KA, Shenvi NV, Clark PC. Arch Phys Med Rehabil; 2012 Apr 15; 93(4):578-87. PubMed ID: 22206630 [Abstract] [Full Text] [Related]
20. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients. Elovic EP, Brashear A, Kaelin D, Liu J, Millis SR, Barron R, Turkel C. Arch Phys Med Rehabil; 2008 May 15; 89(5):799-806. PubMed ID: 18452724 [Abstract] [Full Text] [Related] Page: [Next] [New Search]